1st European Ovarian Cancer Research Symposium- May 2026

📍Bergen, Norway 🇳🇴

We are proud to share that our laboratory recently participated in the Ovarian Cancer Research symposium in Norway.

Dr. Michael Anglesio delivered an insightful and impactful talk on “Integrating Molecular Subtypes and Hormone Receptors Improves Outcome Prediction: A Multi-National Endometrioid Ovarian Cancer Collaborative (MECC) Study", building on work previously developed within our laboratory. The talk reflected the strength and depth of the ongoing research in this field. We would like to extend our sincere thanks to Dr. Bianca Ribeiro de Souza for her valuable contributions to the work presented.

We also had the pleasure of having our visiting PhD student from Sweden, Sara Schumacher, present a poster entitled “Rethinking the Precursor Landscape: Clonal Concordance and Divergence in Normal Biopsies, Endometrial Intraepithelial Neoplasia, and Endometrial Carcinoma,” contributing to the vibrant scientific exchange.

The conference provided an excellent platform for meaningful discussions, new collaborations, and future opportunities.

And of course, beyond the science, the stunning landscapes of Norway made this experience even more memorable.

We look forward to continued collaborations and future engagements.